Antioxidant effect of dipyridamole (DIP) and its derivative RA 25 upon lipid peroxidation and hemolysis in red blood cells
- PMID: 10970046
Antioxidant effect of dipyridamole (DIP) and its derivative RA 25 upon lipid peroxidation and hemolysis in red blood cells
Abstract
The antioxidant effects of dipyridamol (DIP), a coronary vasodilator, and its derivative RA-25 were compared in intact red blood cells (RBC) and in isolated ghost membranes. Both compounds are quite effective antioxidants in cumene hydroperoxide-induced lipid peroxidation of RBC, showing a much smaller effect for hydrogen peroxide oxidation. The antioxidant effect of DIP was considerably higher than that of RA25. For isolated ghost membranes, the apparent IC50 (the drug concentration that produces 50% inhibition of lipid peroxidation) in cumene hydroperoxide-induced peroxidation was 25 microM, while the maximum protective effect of RA-25 was around 30% in the drug concentration range of 50-100 microM. The drugs can protect the oxidative hemolysis induced by cumene hydroperoxide with a lower effect when the hemolysis is induced by H2O2. The significant antioxidant effect against damages induced by cumene hydroperoxide suggests that DIP, due to its lipophilic character, can interact with RBC membranes, and the protective effect is associated with the binding of the drug to the membrane. On the other hand, RA-25 is more hydrophilic than DIP, binds to the membrane to a smaller extent, and, for this reason, has a lower antioxidant effect.
Similar articles
-
Membrane cholesterol contents influence the protective effects of quercetin and rutin in erythrocytes damaged by oxidative stress.Chem Biol Interact. 2006 May 15;161(1):79-91. doi: 10.1016/j.cbi.2006.03.004. Epub 2006 Mar 12. Chem Biol Interact. 2006. PMID: 16620793
-
Destabilisation and subsequent lysis of human erythrocytes induced by Plasmodium falciparum haem products.Eur J Haematol. 2005 Apr;74(4):324-32. doi: 10.1111/j.1600-0609.2004.00352.x. Eur J Haematol. 2005. PMID: 15777345
-
Hydroxynimesulide, the main metabolite of nimesulide, prevents hydroperoxide/hemoglobin-induced hemolysis of rat erythrocytes.Drugs Exp Clin Res. 1997;23(5-6):157-65. Drugs Exp Clin Res. 1997. PMID: 9515225
-
Interaction of different extracts of Primula heterochroma Stapf. with red blood cell membrane lipids and proteins: antioxidant and antihemolytic effects.J Diet Suppl. 2012 Dec;9(4):285-92. doi: 10.3109/19390211.2012.726705. Epub 2012 Oct 22. J Diet Suppl. 2012. PMID: 23083407 Review.
-
Recent approaches for reducing hemolytic activity of chemotherapeutic agents.J Control Release. 2015 Aug 10;211:10-21. doi: 10.1016/j.jconrel.2015.06.001. Epub 2015 Jun 3. J Control Release. 2015. PMID: 26047758 Review.
Cited by
-
Dipyridamole decreases dialysis risk and improves survival in patients with pre-dialysis advanced chronic kidney disease.Oncotarget. 2017 Aug 3;9(4):5368-5377. doi: 10.18632/oncotarget.19850. eCollection 2018 Jan 12. Oncotarget. 2017. PMID: 29435184 Free PMC article.
-
Dipyridamole treatment is associated with improved renal outcome and patient survival in advanced chronic kidney disease.Kaohsiung J Med Sci. 2014 Dec;30(12):599-607. doi: 10.1016/j.kjms.2014.10.002. Epub 2014 Oct 28. Kaohsiung J Med Sci. 2014. PMID: 25476097 Free PMC article.